Impact of an oral gonadotropin‐releasing hormone antagonist on severe ovarian hyperstimulation syndrome in a patient with breast cancer who received a sustained‐release gonadotropin‐releasing hormone agonist: A case report
Postoperative hormone therapy for hormone‐sensitive patients with breast cancer is important to prevent a recurrence. As hormone therapy does not induce infertility in patients, fertility‐preserving therapy is not provided during treatment. Here, however, we performed controlled ovarian stimulation...
Saved in:
| Published in | The journal of obstetrics and gynaecology research Vol. 47; no. 12; pp. 4472 - 4477 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Kyoto, Japan
John Wiley & Sons Australia, Ltd
01.12.2021
Wiley Subscription Services, Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1341-8076 1447-0756 1447-0756 |
| DOI | 10.1111/jog.15059 |
Cover
| Abstract | Postoperative hormone therapy for hormone‐sensitive patients with breast cancer is important to prevent a recurrence. As hormone therapy does not induce infertility in patients, fertility‐preserving therapy is not provided during treatment. Here, however, we performed controlled ovarian stimulation and embryo freezing for fertility preservation under the influence of a sustained‐release gonadotropin‐releasing hormone agonist in a patient with breast cancer whose postoperative treatment plan was changed from hormone therapy to chemotherapy. After oocyte retrieval, the patient developed treatment‐resistant severe symptomatic ovarian hyperstimulation syndrome. Following treatment with oral gonadotropin‐releasing hormone antagonist, her symptoms immediately improved, and she could receive chemotherapy on schedule. |
|---|---|
| AbstractList | Postoperative hormone therapy for hormone‐sensitive patients with breast cancer is important to prevent a recurrence. As hormone therapy does not induce infertility in patients, fertility‐preserving therapy is not provided during treatment. Here, however, we performed controlled ovarian stimulation and embryo freezing for fertility preservation under the influence of a sustained‐release gonadotropin‐releasing hormone agonist in a patient with breast cancer whose postoperative treatment plan was changed from hormone therapy to chemotherapy. After oocyte retrieval, the patient developed treatment‐resistant severe symptomatic ovarian hyperstimulation syndrome. Following treatment with oral gonadotropin‐releasing hormone antagonist, her symptoms immediately improved, and she could receive chemotherapy on schedule. Postoperative hormone therapy for hormone-sensitive patients with breast cancer is important to prevent a recurrence. As hormone therapy does not induce infertility in patients, fertility-preserving therapy is not provided during treatment. Here, however, we performed controlled ovarian stimulation and embryo freezing for fertility preservation under the influence of a sustained-release gonadotropin-releasing hormone agonist in a patient with breast cancer whose postoperative treatment plan was changed from hormone therapy to chemotherapy. After oocyte retrieval, the patient developed treatment-resistant severe symptomatic ovarian hyperstimulation syndrome. Following treatment with oral gonadotropin-releasing hormone antagonist, her symptoms immediately improved, and she could receive chemotherapy on schedule.Postoperative hormone therapy for hormone-sensitive patients with breast cancer is important to prevent a recurrence. As hormone therapy does not induce infertility in patients, fertility-preserving therapy is not provided during treatment. Here, however, we performed controlled ovarian stimulation and embryo freezing for fertility preservation under the influence of a sustained-release gonadotropin-releasing hormone agonist in a patient with breast cancer whose postoperative treatment plan was changed from hormone therapy to chemotherapy. After oocyte retrieval, the patient developed treatment-resistant severe symptomatic ovarian hyperstimulation syndrome. Following treatment with oral gonadotropin-releasing hormone antagonist, her symptoms immediately improved, and she could receive chemotherapy on schedule. |
| Author | Kitazawa, Jun Murakami, Takashi Hanada, Tetsuro Kimura, Fuminori Morimune, Aina |
| Author_xml | – sequence: 1 givenname: Tetsuro orcidid: 0000-0001-8183-9702 surname: Hanada fullname: Hanada, Tetsuro email: thanada@belle.shiga-med.ac.jp organization: Shiga University of Medical Science – sequence: 2 givenname: Fuminori orcidid: 0000-0002-9840-4227 surname: Kimura fullname: Kimura, Fuminori organization: Shiga University of Medical Science – sequence: 3 givenname: Jun surname: Kitazawa fullname: Kitazawa, Jun organization: Shiga University of Medical Science – sequence: 4 givenname: Aina surname: Morimune fullname: Morimune, Aina organization: Shiga University of Medical Science – sequence: 5 givenname: Takashi surname: Murakami fullname: Murakami, Takashi organization: Shiga University of Medical Science |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34636462$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNks9u1DAQhyNURP_AgRdAlriUw7Z27DgOt6qCUlSpFzhHjj3Z9Sqxw9jZ1d54BJ4R8SC43dJDJRC-2LK_-fyTZo6LAx88FMVrRs9YXufrsDxjFa2aZ8URE6Je0LqSB_nMBVsoWsvD4jjGNaWsbph6URxyIbkUsjwqfl2PkzaJhJ5oTwLqgSyD1zYkDJPzP7__QBhAR-eXZBVwzB9nMOkMuZjLPImwAQQSNhpdVqx2E2BMbpwHndzd-85bDCMQ54kmU74En8jWpRXpMJsTMdobQLJdBYJgwG3AZjLOMWnnwT5mgP-Its_1nlxkay5AmAKml8XzXg8RXj3sJ8XXjx--XH5a3NxeXV9e3CyMUHWzEMpKK7q-L2tbiQZ4pUojrOp4ZSVIYavGMEkrbpXWRvdUNL0wDVW85h3ojp8Up3vvhOHbDDG1o4sGhkF7CHNsy0qxUglWsoy-fYKuw4w-p2tLmcUlF5Rn6s0DNXcj2HZCN2rctX_6l4F3e8BgiBGhf0QYbe9mI2uX7f1sZPb8CWtcuu9RQu2Gf1Vs3QC7v6vbz7dX-4rfc8jUAQ |
| CitedBy_id | crossref_primary_10_1177_26334941231196545 crossref_primary_10_1007_s40278_022_09983_3 |
| Cites_doi | 10.1016/j.fertnstert.2006.01.046 10.5468/ogs.2017.60.5.449 10.1093/humrep/12.6.1129 10.1016/S1472-6483(11)60211-3 10.1093/humrep/dev060 10.1016/j.fertnstert.2011.12.046 10.1016/j.ajog.2016.08.018 10.1111/1471-0528.12572 10.2165/00003088-200241070-00003 10.1056/NEJMoa1803164 10.1016/S1472-6483(10)60042-9 10.1093/humrep/17.10.2548 |
| ContentType | Journal Article |
| Copyright | 2021 Japan Society of Obstetrics and Gynecology 2021 Japan Society of Obstetrics and Gynecology. |
| Copyright_xml | – notice: 2021 Japan Society of Obstetrics and Gynecology – notice: 2021 Japan Society of Obstetrics and Gynecology. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO H94 K9. 7X8 |
| DOI | 10.1111/jog.15059 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic CrossRef MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1447-0756 |
| EndPage | 4477 |
| ExternalDocumentID | 34636462 10_1111_jog_15059 JOG15059 |
| Genre | caseStudy Case Reports |
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OB 1OC 29L 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO H94 K9. 7X8 |
| ID | FETCH-LOGICAL-c4879-48d6d4bff27d549e3582c4d8b35d6e64d59c16053d8aacaf049f4c908373beab3 |
| IEDL.DBID | DR2 |
| ISSN | 1341-8076 1447-0756 |
| IngestDate | Fri Jul 11 10:36:32 EDT 2025 Sun Jul 13 03:44:02 EDT 2025 Thu Apr 03 07:07:31 EDT 2025 Wed Oct 01 03:12:59 EDT 2025 Thu Apr 24 23:13:08 EDT 2025 Wed Jan 22 16:27:05 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Keywords | ovarian hyperstimulation syndrome breast cancer gonadotropin-releasing hormone agonist gonadotropin-releasing hormone antagonist oncofertility |
| Language | English |
| License | 2021 Japan Society of Obstetrics and Gynecology. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4879-48d6d4bff27d549e3582c4d8b35d6e64d59c16053d8aacaf049f4c908373beab3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Case Study-2 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
| ORCID | 0000-0001-8183-9702 0000-0002-9840-4227 |
| OpenAccessLink | http://hdl.handle.net/10422/00013109 |
| PMID | 34636462 |
| PQID | 2604923403 |
| PQPubID | 2045132 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_2581284121 proquest_journals_2604923403 pubmed_primary_34636462 crossref_primary_10_1111_jog_15059 crossref_citationtrail_10_1111_jog_15059 wiley_primary_10_1111_jog_15059_JOG15059 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | December 2021 |
| PublicationDateYYYYMMDD | 2021-12-01 |
| PublicationDate_xml | – month: 12 year: 2021 text: December 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Kyoto, Japan |
| PublicationPlace_xml | – name: Kyoto, Japan – name: Australia – name: Hoboken |
| PublicationTitle | The journal of obstetrics and gynaecology research |
| PublicationTitleAlternate | J Obstet Gynaecol Res |
| PublicationYear | 2021 |
| Publisher | John Wiley & Sons Australia, Ltd Wiley Subscription Services, Inc |
| Publisher_xml | – name: John Wiley & Sons Australia, Ltd – name: Wiley Subscription Services, Inc |
| References | 2002; 17 2006; 86 2017; 60 2002; 41 2009; 61 2002; 5 2015; 30 2018; 379 2019; 58 1997; 12 2014; 121 2018; 22 2009; 19 2012; 97 2017; 216 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_9_1 e_1_2_7_8_1 Vuković P (e_1_2_7_3_1) 2019; 58 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 Carneiro MM (e_1_2_7_4_1) 2018; 22 Irahara M (e_1_2_7_7_1) 2009; 61 |
| References_xml | – volume: 86 start-page: 636 year: 2006 end-page: 41 article-title: Gonadotropin‐releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures publication-title: Fertil Steril – volume: 22 start-page: 244 year: 2018 end-page: 52 article-title: Motherhood after breast cancer: can we balance fertility preservation and cancer treatment? A narrative review of the literature publication-title: JBRA Assist Reprod – volume: 379 start-page: 122 year: 2018 end-page: 137 article-title: Tailoring adjuvant endocrine therapy for premenopausal breast cancer publication-title: N Engl J Med – volume: 17 start-page: 2548 year: 2002 end-page: 51 article-title: Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos publication-title: Hum Reprod – volume: 61 start-page: 1138 year: 2009 end-page: 45 article-title: Management and prevention of ovarian hyperstimulation syndrome publication-title: Acta Obstet Gynaecol Jpn – volume: 60 start-page: 449 year: 2017 end-page: 54 article-title: Gonadotropin releasing hormone antagonist administration for treatment of early type severe ovarian hyperstimulation syndrome: a case series publication-title: Obstet Gynecol Sci – volume: 30 start-page: 1437 year: 2015 end-page: 46 article-title: Ovarian reserve after treatment with alkylating agents during childhood publication-title: Hum Reprod – volume: 12 start-page: 1129 year: 1997 end-page: 37 article-title: The pathophysiology of ovarian hyperstimulation syndrome—views and ideas publication-title: Hum Reprod – volume: 121 start-page: 848 year: 2014 end-page: 55 article-title: Serum vascular endothelial growth factor levels following luteal gonadotrophin‐releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome publication-title: BJOG – volume: 97 start-page: 517 year: 2012 end-page: 22 article-title: Etiology of OHSS and use of dopamine agonists publication-title: Fertil Steril – volume: 216 start-page: 42.e1 year: 2017 end-page: e10 article-title: Effect of letrozole on moderate and severe early‐onset ovarian hyperstimulation syndrome in high‐risk women: a prospective randomized trial publication-title: Am J Obstet Gynecol – volume: 41 start-page: 485 year: 2002 end-page: 504 article-title: Clinical pharmacokinetics of depot leuprorelin publication-title: Clin Pharmacokinet – volume: 19 start-page: 28 year: 2009 end-page: 32 article-title: Symposium: update on prediction and management of OHSS. A modern classification of OHSS publication-title: Reprod Biomed Online – volume: 58 start-page: 147 year: 2019 end-page: 56 article-title: Fertility preservation in young women with early‐stage breast cancer publication-title: Acta Clin Croat – volume: 5 start-page: 8 issue: Suppl 1 year: 2002 end-page: 13 article-title: Direct ovarian effects and safety aspects of GnRH agonists and antagonists publication-title: Reprod Biomed Online – ident: e_1_2_7_11_1 doi: 10.1016/j.fertnstert.2006.01.046 – volume: 58 start-page: 147 year: 2019 ident: e_1_2_7_3_1 article-title: Fertility preservation in young women with early‐stage breast cancer publication-title: Acta Clin Croat – ident: e_1_2_7_12_1 doi: 10.5468/ogs.2017.60.5.449 – ident: e_1_2_7_8_1 doi: 10.1093/humrep/12.6.1129 – volume: 22 start-page: 244 year: 2018 ident: e_1_2_7_4_1 article-title: Motherhood after breast cancer: can we balance fertility preservation and cancer treatment? A narrative review of the literature publication-title: JBRA Assist Reprod – volume: 61 start-page: 1138 year: 2009 ident: e_1_2_7_7_1 article-title: Management and prevention of ovarian hyperstimulation syndrome publication-title: Acta Obstet Gynaecol Jpn – ident: e_1_2_7_14_1 doi: 10.1016/S1472-6483(11)60211-3 – ident: e_1_2_7_2_1 doi: 10.1093/humrep/dev060 – ident: e_1_2_7_9_1 doi: 10.1016/j.fertnstert.2011.12.046 – ident: e_1_2_7_10_1 doi: 10.1016/j.ajog.2016.08.018 – ident: e_1_2_7_13_1 doi: 10.1111/1471-0528.12572 – ident: e_1_2_7_15_1 doi: 10.2165/00003088-200241070-00003 – ident: e_1_2_7_5_1 doi: 10.1056/NEJMoa1803164 – ident: e_1_2_7_6_1 doi: 10.1016/S1472-6483(10)60042-9 – ident: e_1_2_7_16_1 doi: 10.1093/humrep/17.10.2548 |
| SSID | ssj0017918 |
| Score | 2.2783854 |
| Snippet | Postoperative hormone therapy for hormone‐sensitive patients with breast cancer is important to prevent a recurrence. As hormone therapy does not induce... Postoperative hormone therapy for hormone-sensitive patients with breast cancer is important to prevent a recurrence. As hormone therapy does not induce... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 4472 |
| SubjectTerms | Agonists Breast cancer Breast Neoplasms - drug therapy Cancer therapies Case reports Chemotherapy Delayed-Action Preparations Endocrine therapy Female Fertility Fertilization in Vitro Freezing Gonadotropin-Releasing Hormone Gonadotropins gonadotropin‐releasing hormone agonist gonadotropin‐releasing hormone antagonist Humans Infertility oncofertility Ovarian hyperstimulation syndrome Ovarian Hyperstimulation Syndrome - chemically induced Ovaries Ovulation Induction Patients Pituitary (anterior) |
| Title | Impact of an oral gonadotropin‐releasing hormone antagonist on severe ovarian hyperstimulation syndrome in a patient with breast cancer who received a sustained‐release gonadotropin‐releasing hormone agonist: A case report |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjog.15059 https://www.ncbi.nlm.nih.gov/pubmed/34636462 https://www.proquest.com/docview/2604923403 https://www.proquest.com/docview/2581284121 |
| Volume | 47 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 1341-8076 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1447-0756 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017918 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSxxBEG7Eg3hJfCVZY0IZPOQyizPd81g9Scj6ACOIgofA0M9dUWfCPhLwlJ-Q3yj5IanqeeBqBPE2MDXTNUx19VddVV8ztuXSxFquokBmqQhEFpmgJyQPaMM_UU5n2u_pHn9LDs7F0UV8Mcd2m16Yih-i3XCjmeH9NU1wqcb3J3k56CKaial5L-SxT9GettRRxLrp2-DQSxPhblKzCvkqnubJ2bXoEcCcxat-wem_Zt8bVas6k6vudKK6-vYBi-MLv2WJvaqBKOxVlrPM5myxwhaO61T7Kvt76PsnoXQgC6A-fhggascgdkQ9Vne__9BxK5K2GmCIwLcsLApSjou4eKEsANdcO7JQ_sRwHF8xxIgXoeblTX1gGDRkCXBZgISa4BVoYxgUlcpPQJNJjuDXsAR0zBYds0HJcdXzZU2rg32GapVeO7CHb8UHqlzJGjvvfz37chDUR0IEGiOrHhqTSYxQzkWpwcjWUp-vFiZTPDaJTYSJezrECI2bTEotHcY_Tuge4syUKysVf8PmCxz1HYPtGG9ncWS40yjlFCIxTVxAaSgQJPMO-9wYR65rvnQ6tuM6b-OmcpD7v9Zhn1rRHxVJyP-ENhoLy2s_Mc4xmiSGPLGNw222t3GGU9pGFracokycEYgIo7DD3laW2Y7Cie9NJBEq6-3r6eHzo5N9f7H-fNH3bDGiEh5fvbPB5iejqf2AGGyiPvrJ9g_ziDX4 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxRBEC5iBPXiW7MatRQPXmbJTve8xEtQ4yZmI0gCucjQz91gnJHNroInf4K_UfwhVvU8MD4geBuYmukapqr6q-qurwEe-yx1Tug4UnkmI5nHNiqkEhEX_FPtTW5CTXeyl44P5M5hcrgCz7pemIYfoi-4sWeEeM0OzgXpX728ng4JziTFOTjP63Psli_e9uRRzLsZGuEoTjPlbtryCoV9PN2jp2ejPyDmacQappytK_CuU7bZafJ-uFzoofnyG4_j_37NVbjcYlHcbIznGqy46jpcmLSr7Tfgx3ZoocTao6qQW_lxSsCd8tg5t1l9__qNT1xRXG3AGWHfunIkyMtcTMeLdYU07bq5w_oTZeT0ihklvYQ2jz60Z4Zhx5eARxUqbDlekWvDqHm3_AINW-UcP89qpNjsKDZbkjxp2r6c7XVwZ1Ct0espbtJb6YFmueQmHGy93H8-jtpTISJDyVVB9mRTK7X3cWYpuXXc6mukzbVIbOpSaZPCjChJEzZXyihPKZCXpiComQntlBa3YLWiUdcANxK6nSexFd6QlNcExgzTAWUjSThZDOBJZx2laSnT-eSO47JPneppGf7aAB71oh8bnpC_Ca13Jla2oeKkpISSSfLkBg33sL9NTs4rN6py9ZJkkpxxxCgeDeB2Y5r9KIIp32Qak7LBwP49fLnz5lW4uHN20Qdwcbw_2S13t_de34VLMe_oCZt51mF1MV-6ewTJFvp-8LyfE-U6FA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9RADLbaIlVceD8WCjWIA5esuslkksCpApa20IIQlXpAiua5WwFJtd0FiRM_gd-I-CHYk4doAanqLVKczESxPZ899jcAj3wmnUt0HKk8E5HIYxsVQiURJ_yl9iY3Iae7uye39sXOQXqwBE-7XpiGH6JPuLFlBH_NBn5k_Z9GXk-GhGbSYhkuCEnRFSOidz13FNNuhj44ctPMuCtbWqFQxtM9enIx-gthngSsYcUZX4YP3VybQpOPw8VcD823UzSO5_yYK3CpRaK42ajOVVhy1TVY3W332q_Dr-3QQIm1R1UhN_LjhGA7RbEzbrL6-f0Hn7eiONeAU0K-deVIkDe5mIwX6wpp0XUzh_UXisfpFVMKeQlrHn5uTwzDji0BDytU2DK8ImeGUXOt_BwN6-QMv05rJM_syDNbkjxumr6c7efgzjC1Zl5PcJPeSg80myU3YH_84v2zrag9EyIyFFoVpE1WWqG9jzNLoa3jRl8jbK6T1EonhU0LM6IQLbG5UkZ5CoC8MAUBzSzRTunkJqxUNOptwI2UbudpbBNvSMprgmKGyYCykSCUnAzgcaccpWkJ0_ncjk9lHzjVkzL8tQE87EWPGpaQfwmtdRpWto7iuKRwkinyxAYN96C_TSbO-zaqcvWCZNKcUcQoHg3gVqOZ_SgJE74JGdNkg379f_hy583LcHHn7KLrsPr2-bh8vb336i5cjLmcJ1TyrMHKfLZw9wiPzfX9YHe_AVMeOMM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+an+oral+gonadotropin%E2%80%90releasing+hormone+antagonist+on+severe+ovarian+hyperstimulation+syndrome+in+a+patient+with+breast+cancer+who+received+a+sustained%E2%80%90release+gonadotropin%E2%80%90releasing+hormone+agonist%3A+A+case+report&rft.jtitle=The+journal+of+obstetrics+and+gynaecology+research&rft.au=Hanada%2C+Tetsuro&rft.au=Kimura%2C+Fuminori&rft.au=Kitazawa%2C+Jun&rft.au=Morimune%2C+Aina&rft.date=2021-12-01&rft.pub=John+Wiley+%26+Sons+Australia%2C+Ltd&rft.issn=1341-8076&rft.eissn=1447-0756&rft.volume=47&rft.issue=12&rft.spage=4472&rft.epage=4477&rft_id=info:doi/10.1111%2Fjog.15059&rft.externalDBID=10.1111%252Fjog.15059&rft.externalDocID=JOG15059 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-8076&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-8076&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-8076&client=summon |